Using PSMA-1007 Imaging for Prostate Cancer Staging
Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer
Recruiting
Observational Study
Prostate Cancer (Adenocarcinoma)
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Heinrich-Heine University, Duesseldorf · Other
Who this trial is looking for
This trial is looking for adults who have just been diagnosed with prostate cancer. Participants will undergo a specific PET/CT scan to help understand how well the new imaging method works in real-world situations.
Are You a Good Fit for This Trial?
You may be able to join if
- I am over 18 years old
- I have been diagnosed with prostate cancer for the first time
- I can provide informed consent for the study
You may not be able to join if
- I have technical errors that limit the quality of imaging results
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The introduction of PSMA diagnostics and therapy has fundamentally changed the treatment management of prostate cancer and has significantly replaced other clinical and radiological diagnostic methods. As a result, 18F-PSMA-1007 (Radelumin®) was approved in Germany and several EU countries, most recently in Germany in 01/2024, for use in primary staging of high-risk prostate cancer and re-staging …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* \> 18 years
* Planned \[18F\]PSMA-1007 PET/CT examination in patients with a first diagnosis of prostate cancer
* Informed consent
Exclusion Criteria:
\- Examinations with limited assessability due to technical errors, such as imaging artifacts.
Contacts